BANK VONTOBEL/PUT/MEDTRONIC/84/0.1/20.12.24 Share Price

Warrant

DE000VD3SFE6

Market Closed - Boerse Frankfurt Warrants 11:12:52 08/07/2024 pm IST
0.76 EUR +7.04% Intraday chart for BANK VONTOBEL/PUT/MEDTRONIC/84/0.1/20.12.24
Current month+22.58%
1 month+76.74%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
08/24/08 0.76 +7.04%
05/24/05 0.71 -4.05%
04/24/04 0.74 0.00%
03/24/03 0.74 -3.90%
02/24/02 0.77 +5.48%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 11:12 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SFE
ISINDE000VD3SFE6
Date issued 09/04/2024
Strike 84 $
Maturity 20/12/2024 (165 Days)
Parity 10 : 1
Emission price 0.54
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.78
Lowest since issue 0.36
Delta-0.71x
Omega 6.552
Premium1.46x
Gearing9.28x
Moneyness 1.093
Difference Strike 7.16 $
Difference Strike %+8.52%
Spread 0.01
Spread %1.30%
Theoretical value 0.7650
Implied Volatility 21.17 %
Total Loss Probability 27.81 %
Intrinsic value 0.6615
Present value 0.1035
Break even 75.72 €
Theta-0x
Vega0.02x
Rho-0.01x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
76.84 USD
Average target price
94.02 USD
Spread / Average Target
+22.36%
Consensus